Samuel D Colella

Samuel D Colella has an estimated net worth of $4.9 Million. This is based on reported shares across multiple companies, which include FLUIDIGM CORP, INSULET CORP, PHASERX, INC., Alexza Pharmaceuticals Inc., Flexion Therapeutics Inc, SYMYX TECHNOLOGIES INC, GLAUKOS Corp, VERACYTE, INC., JAZZ PHARMACEUTICALS INC, Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, NOVACEA INC, THERMAGE INC, GENOMIC HEALTH INC, INTRALASE CORP, HELICOS BIOSCIENCES CORP, ARGONAUT TECHNOLOGIES INC, TURNSTONE SYSTEMS INC, DIGITAL IMPACT INC /DE/, and AT ROAD INC.

2012 was Samuel D Colella's most active year for acquiring shares with 14 total transactions. Samuel D Colella's most active month to acquire stocks was the month of May. 2012 was Samuel D Colella's most active year for disposing of shares, totalling 10 transactions. Samuel D Colella's most active month to dispose stocks was the month of December. 2012 saw Samuel D Colella paying a total of $849,730.05 for 99,925 shares, this is the most they've acquired in one year. In 2015 Samuel D Colella cashed out on 106,680 shares for a total of $2,076,233.98, their largest year based on trade value.